In conclusion, our results provide evidence that high Nrf2 expression inhibites MSH2 expression through activating the JNK/c-Jun signaling pathway, playing a key role in the frequency of gene mutation in tumor cells, thus achieving chemoresistance in AML. This evidence concerns the gene MSH2 and acute myeloid leukemia.